Elevated plasma adiponectin in humans with genetically defective insulin receptors.
The Journal of clinical endocrinology and metabolism 2006 ; 91: 3219-23.
Semple RK, Soos MA, Luan J, Mitchell CS, Wilson JC, Gurnell M, Cochran EK, Gorden P, Chatterjee VK, Wareham NJ, and O'Rahilly S
DOI : 10.1210/jc.2006-0166
PubMed ID : 16705075
PMCID : 0
Adiponectin has been suggested to play a role in the etiopathogenesis of at least some forms of insulin resistance, in part based on a strong correlation between plasma levels of adiponectin and measures of insulin sensitivity.
The objective of the study was to establish whether this relationship is maintained at extreme levels of insulin resistance.
This was a cross-sectional study in a university teaching hospital of subjects recruited from the United Kingdom and the United States.
Participants included 75 subjects with a range of syndromes of severe insulin resistance and 872 nondiabetic controls.
Fasting plasma insulin, adiponectin, and leptin were measured.
Unexpectedly, subjects with mutations in the insulin receptor, despite having the most severe degree of insulin resistance, had elevated plasma adiponectin [median 24.4 mg/liter; range 6.6-36.6 (normal adult range for body mass index 20 kg/m(2) = 3-19 mg/liter)], whereas all other subjects had low adiponectin levels (median 2.0 mg/liter; range 0.12-11.2). Plasma leptin in all but one subject with an insulin receptoropathy was low or undetectable [median 0.5 ng/ml; range 0-16: normal adult range for body mass index of < 25 kg/m(2) = 2.4-24.4 (female) and 0.4-8.3 ng/ml (male)].
We conclude that the relationship between plasma adiponectin and insulin sensitivity is complex and dependent on the precise etiology of defective insulin action and that the combination of high plasma adiponectin with low leptin may have clinical utility in patients with severe insulin resistance as a marker of the presence of a genetic defect in the insulin receptor.